VAERS Reports U014143

VAERS 1754039

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U014143

mild

Staat: CT
Alter: 4,0
Geschlecht: F
Eingang: 01.10.2021
Impfdatum: 01.10.2021
Beginn: 01.10.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: SC / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Erythema Immediate post-injection reaction Rash

Symptomtext

Patient develop redness and a rash on the face almost immediately. Patient was administered 7.5 mL Benadryl

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: N/A
Andere Medikamente: None
Allergien: NKA
Vorherige Impfungen: -

VAERS 2369852

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U014143

gering

Staat: TX
Alter: 4,0
Geschlecht: M
Eingang: 15.07.2022
Impfdatum: 25.05.2022
Beginn: 25.05.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Product storage error

Symptomtext

"patient had no adverse reactions"; Caller states that improperly stored vaccine was "possibly" administered on unknown dates to unknown patients./patient was administered PROQUAD on 25-MAY-2022, which had been incorrectly stored in the refrigerator.; This spontaneous report has been received from a nurse and refers to an unspecified number of patients of unknown age and gender. The patient's pertinent medical history, previous drug reactions or allergies, and concomitant therapies were not reported. On an unknown date, there was an improperly storage for measles, mumps, rubella, and varicella (oka-merck) virus vaccine live (recombinant human albumin) (PROQUAD), rHA lot number U014143 has been verified to be valid, expiration date: 31-OCT-2022, administered for prophylaxis (strength, dose, anatomical location of vaccination and route of administration were not provided), (product storage error). It was accidentally stored in the refrigerator with a temperature of 38 degree Fahrenheit (F) for a time frame of 168 hours. Moreover, on an unknown date, that improperly storage vaccine was possibly administered to unidentified patients. No previous temperature excursion was reported. Follow information has been received on from the registered nurse 11-JUL-2022. A call was received from the Nurse Practitioner reporting information on a 4-year-old male child with a history of asthma (well-controlled). Concomitant medications included diphtheria vaccine toxoid, pertussis vaccine acellular 3-component, polio vaccine inact 3v (vero), tetanus vaccine toxoid (KINRIX). There was no known drug allergies. On 25-MAY-2022, the patient was vaccinated with measles, mumps, rubella and varicella (Oka-Merck) virus vaccine live (PROQUAD), which had been incorrectly stored in the refrigerator. It was administered subcutaneously in the left arm. There was no adverse reactions.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Asthma ((well-controlled))
Vorgeschichte: -
Andere Medikamente: KINRIX
Allergien: -
Vorherige Impfungen: -

VAERS 1901047

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U014143

gering

Staat: IN
Alter: 1,0
Geschlecht: U
Eingang: 26.11.2021
Impfdatum: 22.11.2021
Beginn: 22.11.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Extra dose administered

Symptomtext

The patient has had no known side effects; Extra dose of Varicella being given; Extra dose of Varicella being given; Proquad and Varivax were administered to a patient today, istead of MMR-II and Varivax; This spontaneous report has been received from a medical assistant, concerning a 12 month old patient of unknown gender. The patient's concurrent conditions, pertinent medical history, drug reactions/allergies, and concomitant medications were not reported. The reporter stated that on 22-NOV-2021, the patient was vaccinated with an extra dose of varicella (Overdose), since she/he received a dose of varicella virus vaccine live (oka/merck)(VARIVAX), 0.5 milliliter, subcutaneous (lot # T021825, which has been verified to be a valid lot number for varicella virus vaccine live (oka/merck), expiration date of 25-JUN-2022), and also was vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) 0.5 milliliter, subcutaneous (lot # U014143, which has been verified to be a valid lot number for measles, mumps, rubella and varicella (oka-merck) virus vaccine live, expiration date of 31-OCT-2022), both as prophylaxis; instead of being vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) and varicella virus vaccine live (oka/merck)(VARIVAX). The patient had no known side effects.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -